Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study
Author:
Funder
Bayer
Publisher
Elsevier BV
Subject
Hematology
Reference27 articles.
1. Preventing pulmonary embolism and deep vein thrombosis: a ‘call to action’ for vascular medicine specialists;Goldhaber;J. Thromb. Haemost.,2007
2. Antithrombotic therapy for vte disease: chest guideline and expert panel report;Kearon;Chest,2016
3. Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials;Limone;Thromb. Res.,2013
4. Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism;Coleman;J. Med. Econ.,2017
5. The long-term clinical course of acute deep venous thrombosis;Prandoni;Ann. Intern. Med.,1996
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study;BMC Pharmacology and Toxicology;2023-12-13
2. Long term survival at 6 and 12 months in venous thromboembolic disease in patients anticoagulated with rivaroxaban and warfarin: propensity score matching study;2023-08-11
3. Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countries;2023-04-17
4. Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010-2020;JAMA Network Open;2023-03-22
5. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism;JAMA;2022-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3